Berberine for Metabolic Syndrome

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Metabolic SyndromeBerberine - DietarySupplement
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is studying the effects of berberine on cholesterol and blood sugar levels, and how well it is tolerated.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

Study Objectives

2 Primary · 1 Secondary · Reporting Duration: Week 4, Week 8, and Week 12

Baseline to week 12
Change in Hemoglobin A1c
Change in LDL Cholesterol
Week 12
Number of participants with adverse events

Trial Safety

Safety Progress

1 of 3

Similar Trials

Trial Design

2 Treatment Groups

Berberine
1 of 2
Identical Placebo
1 of 2

Experimental Treatment

Non-Treatment Group

40 Total Participants · 2 Treatment Groups

Primary Treatment: Berberine · Has Placebo Group · N/A

Berberine
DietarySupplement
Experimental Group · 1 Intervention: Berberine · Intervention Types: DietarySupplement
Identical Placebo
Other
PlaceboComparator Group · 1 Intervention: Identical Placebo · Intervention Types: Other
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Berberine
2016
Completed Phase 4
~3180

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: week 4, week 8, and week 12

Who is running the clinical trial?

University of Kansas Medical CenterLead Sponsor
401 Previous Clinical Trials
158,329 Total Patients Enrolled
2 Trials studying Metabolic Syndrome
121 Patients Enrolled for Metabolic Syndrome
James Backes, PharmDPrincipal Investigator - University of Kansas Medical Center
University of Kansas Medical Center

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Who else is applying?

How old are they?
18 - 65100.0%
What portion of applicants met pre-screening criteria?
Did not meet criteria100.0%